Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gittelman

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
An Allogeneic Multiple Myeloma GM-CSF-Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete RemissionLuca Biavati, Carol Ann Huff, Anna Ferguson, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severityRebecca Elyanow, Thomas M Snyder, Sudeb C Dalai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2022
Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 InfectionSudeb C Dalai, Jennifer N Dines, Thomas M Snyder, et al.
Journal for Immunotherapy of Cancer|September 1, 2021
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomesBrett A Schroeder, Natalie A LaFranzo, Bonnie J LaFleur, et al.
Inflammatory Bowel Diseases|April 9, 2022
The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF TherapyDalin Li, Alexander Xu, Emebet Mengesha, et al.
JCI Insight|April 19, 2022
T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severityRebecca Elyanow, Thomas M Snyder, Sudeb C Dalai, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-respondersDalin Li, Alexander Xu, Emebet Mengesha, et al.
Journal of Crohn'S & Colitis|March 22, 2025
Antigen-driven expansion of public clonal T cell populations in inflammatory bowel diseasesMitchell Pesesky, Ramit Bharanikumar, Lionel Le Bourhis, et al.
Frontiers in Immunology|April 25, 2022
Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel DiseaseAlexander M Xu, Dalin Li, Joseph E Ebinger, et al.
JCI Insight|April 19, 2022
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infectionRachel M Gittelman, Enrico Lavezzo, Thomas M Snyder, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
An Allogeneic Multiple Myeloma GM-CSF-Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete RemissionLuca Biavati, Carol Ann Huff, Anna Ferguson, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severityRebecca Elyanow, Thomas M Snyder, Sudeb C Dalai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2022
Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 InfectionSudeb C Dalai, Jennifer N Dines, Thomas M Snyder, et al.
Journal for Immunotherapy of Cancer|September 1, 2021
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomesBrett A Schroeder, Natalie A LaFranzo, Bonnie J LaFleur, et al.
Inflammatory Bowel Diseases|April 9, 2022
The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF TherapyDalin Li, Alexander Xu, Emebet Mengesha, et al.
JCI Insight|April 19, 2022
T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severityRebecca Elyanow, Thomas M Snyder, Sudeb C Dalai, et al.
Medrxiv : the Preprint Server for Health Sciences|December 15, 2021
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-respondersDalin Li, Alexander Xu, Emebet Mengesha, et al.
Journal of Crohn'S & Colitis|March 22, 2025
Antigen-driven expansion of public clonal T cell populations in inflammatory bowel diseasesMitchell Pesesky, Ramit Bharanikumar, Lionel Le Bourhis, et al.
Frontiers in Immunology|April 25, 2022
Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel DiseaseAlexander M Xu, Dalin Li, Joseph E Ebinger, et al.
JCI Insight|April 19, 2022
Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infectionRachel M Gittelman, Enrico Lavezzo, Thomas M Snyder, et al.
Pageof 6